Augmentation of neovascularization in murine hindlimb ischemia by combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells transplantation

Journal of Biomedical Science

Volumn 17, Issue 1, 2010, Pages

  Li, Yong ^a,b   Zhang, Dingguo ^a   Zhang, Yuqing ^a   He, Guoping ^b   Zhang, Fumin ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b JIANGSU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; SIMVASTATIN; VASCULOTROPIN; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD FLOW; CAPILLARY DENSITY; CELL DIFFERENTIATION; CELL VIABILITY; CLINICAL EVALUATION; CONTROLLED STUDY; DRUG MEGADOSE; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HINDLIMB; IMMUNOHISTOCHEMISTRY; LASER DOPPLER FLOWMETRY; LIMB ISCHEMIA; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NEOVASCULARIZATION (PATHOLOGY); NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; REPERFUSION; TREATMENT OUTCOME; WESTERN BLOTTING; ANALYSIS OF VARIANCE; ANGIOGENESIS; ANIMAL; C57BL MOUSE; DRUG EFFECT; FEMALE; ISCHEMIA; MESENCHYMAL STEM CELL; METABOLISM; METHODOLOGY; MOUSE; MULTIMODALITY CANCER THERAPY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ANIMALIA; MURINAE;

ANALYSIS OF VARIANCE; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; COMBINED MODALITY THERAPY; FEMALE; FLOW CYTOMETRY; HINDLIMB; IMMUNOHISTOCHEMISTRY; ISCHEMIA; LASER-DOPPLER FLOWMETRY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, SPRAGUE-DAWLEY; REGIONAL BLOOD FLOW; SIMVASTATIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77957291465     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-17-75     Document Type: Article

References (31)

1. Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. C Diehm JR Allenberg D Pittrow M Mahn G Tepohl RL Haberl H Darius I Burghaus HJ Trampisch, Circulation 2009 120 2053 2061 10.1161/CIRCULATIONAHA.109.865600 19901192
2. Clinical outcome in patients with peripheral artery disease. Results from a prospective registry (FRENA). M Monreal L Alvarez B Vilaseca R Coll C Suarez J Toril C Sanclemente, Eur J Intern Med 2008 19 192 197 10.1016/j.ejim.2007.09. 003 18395163
3. Multilineage potential of adult human mesenchymal stem cells. MF Pittenger AM Mackay SC Beck RK Jaiswal R Douglas JD Mosca MA Moorman DW Simonetti S Craig DR Marshak, Science 1999 284 143 147 10.1126/science.284.5411. 143 10102814
4. Aging and disease as modifiers of efficacy of cell therapy. S Dimmeler A Leri, Circ Res 2008 102 1319 1330 10.1161/CIRCRESAHA.108.175943 18535269
5. Human mesenchymal stem cells: insights from a surrogate in vivo assay system. TC MacKenzie AW Flake, Cells Tissues Organs 2002 171 90 95 10.1159/000057694 12021494
6. Risk factors for coronary artery disease, circulating endothelial progenitor cells, and the role of HMG-CoA reductase inhibitors. C Urbich S Dimmeler, Kidney Int 2005 67 1672 1676 10.1111/j.1523-1755.2005.00261.x 15840010
7. Increased nitric oxide bioavailability in endothelial cells contributes to the pleiotropic effect of cerivastatin. L Kalinowski LW Dobrucki V Brovkovych T Malinski, Circulation 2002 105 933 938 10.1161/hc0802.104283 11864921
8. Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins. J Haendeler J Hoffmann AM Zeiher S Dimmeler, Circulation 2004 110 856 861 10.1161/01.CIR.0000138743.09012.93 15289372
9. Effects of rosuvastatin and pitavastatin on ischemia-induced myocardial stunning in dogs. K Satoh A Takaguri M Itagaki S Kano K Ichihara, J Pharmacol Sci 2008 106 593 599 10.1254/jphs.08017FP 18403900
10. Effects of atorvastatin on angiogenesis in hindlimb ischemia and endothelial progenitor cell formation in rats. M Matsumura N Fukuda N Kobayashi H Umezawa A Takasaka T Matsumoto EH Yao T Ueno N Negishi, J Atheroscler Thromb 2009 16 319 326 19672036
11. Statins have biphasic effects on angiogenesis. M Weis C Heeschen AJ Glassford JP Cooke, Circulation 2002 105 739 745 10.1161/hc0602.103393 11839631
12. Combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells increases benefits in infarcted swine hearts. YJ Yang HY Qian J Huang JJ Li RL Gao KF Dou GS Yang JT Willerson YJ Geng, Arterioscler Thromb Vasc Biol 2009 29 2076 2082 10.1161/ATVBAHA.109.189662 19762786
13. Statins augment collateral growth in response to ischemia but they do not promote cancer and atherosclerosis. M Sata H Nishimatsu J Osuga K Tanaka N Ishizaka S Ishibashi Y Hirata R Nagai, Hypertension 2004 43 1214 1220 10.1161/01.HYP.0000126186.29571.41 15166180
14. Pluripotency of mesenchymal stem cells derived from adult marrow. Y Jiang BN Jahagirdar RL Reinhardt RE Schwartz CD Keene XR Ortiz-Gonzalez M Reyes T Lenvik T Lund M Blackstad J Du S Aldrich A Lisberg WC Low DA Largaespada CM Verfaillie, Nature 2002 418 41 49 10.1038/nature00870 12077603
15. Combination of simvastatin administration and EPC transplantation enhances angiogenesis and protects against apoptosis for hindlimb ischemia. Z Hu F Zhang Z Yang N Yang D Zhang J Zhang K Cao, J Biomed Sci 2008 15 509 517 10.1007/s11373-008-9243-1 18327656
16. Mouse model of angiogenesis. T Couffinhal M Silver LP Zheng M Kearney B Witzenbichler JM Isner, Am J Pathol 1998 152 1667 1679 9626071
17. Lipopolysaccharide preconditioning enhances the efficacy of mesenchymal stem cells transplantation in a rat model of acute myocardial infarction. Y Yao F Zhang L Wang G Zhang Z Wang J Chen X Gao, J Biomed Sci 2009 16 74 10.1186/1423-0127-16-74 19691857
18. Stromal cell-derived factor-1 enhances pro-angiogenic effect of granulocyte-colony stimulating factor. Y Tan H Shao D Eton Z Yang L Alonso-Diaz H Zhang A Schulick AS Livingstone H Yu, Cardiovasc Res 2007 73 823 832 10.1016/j.cardiores.2006.12.015 17258698
19. Basic science review: Statin therapy - Part I: The pleiotropic effects of statins in cardiovascular disease. B Sadowitz KG Maier V Gahtan, Vasc Endovascular Surg 2010 44 241 251 10.1177/1538574410362922 20403949
20. Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion. J Tang Q Xie G Pan J Wang M Wang, Eur J Cardiothorac Surg 2006 30 353 61 10.1016/j.ejcts.2006. 02.070 16829080
21. Emerging role for bone marrow derived mesenchymal stem cells in myocardial regenerative therapy. JM Zimmet JM Hare, Basic Res Cardiol 2005 100 471 481 10.1007/s00395-005-0553-4 16237508
22. Statin pleiotropy: fact or fiction? LG Futterman L Lemberg, Am J Crit Care 2004 13 244 249 15149060
23. Simvastatin enhances VEGF production and ameliorates impaired wound healing in experimental diabetes. A Bitto L Minutoli D Altavilla F Polito T Fiumara H Marini M Galeano M Calo P Lo Cascio M Bonaiuto A Migliorato AP Caputi F Squadrito, Pharmacol Res 2008 57 159 169 10.1016/j.phrs.2008.01.005 18316203
24. Paracrine effects of cell transplantation: strategies to augment the efficacy of cell therapies. AS Cheng TM Yau, Semin Thorac Cardiovasc Surg 2008 20 94 101 10.1053/j.semtcvs.2008.04.003 18707640
25. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. L Chen EE Tredget PY Wu Y Wu, PLoS One 2008 3 1886 10.1371/journal.pone.0001886 18382669
26. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. M Gnecchi H He N Noiseux OD Liang L Zhang F Morello H Mu LG Melo RE Pratt JS Ingwall VJ Dzau, FASEB J 2006 20 661 669 10.1096/fj.05-5211com 16581974
27. Promoting mechanisms of vascular health: circulating progenitor cells, angiogenesis, and reverse cholesterol transport. PR Moreno J Sanz V Fuster, J Am Coll Cardiol 2009 53 2315 2323 10.1016/j.jacc.2009.02.057 19539140
28. Atorvastatin induction of VEGF and BDNF promotes brain plasticity after stroke in mice. J Chen C Zhang H Jiang Y Li L Zhang A Robin M Katakowski M Lu M Chopp, J Cereb Blood Flow Metab 2005 25 281 290 10.1038/sj.jcbfm.9600034 15678129
29. Disparate effects of simvastatin on angiogenesis during hypoxia and inflammation. XY Zhu E Daghini AR Chade R Lavi C Napoli A Lerman LO Lerman, Life Sci 2008 83 801 809 10.1016/j.lfs.2008.09.029 18976673
30. Bcl-2 upregulation and neuroprotection in guinea pig brain following chronic simvastatin treatment. C Franke M Noldner R Abdel-Kader LN Johnson-Anuna W Gibson Wood WE Muller GP Eckert, Neurobiol Dis 2007 25 438 445 10.1016/j.nbd.2006.10.004 17157514
31. Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells. A Kortesidis A Zannettino S Isenmann S Shi T Lapidot S Gronthos, Blood 2005 105 3793 3801 10.1182/blood-2004-11-4349 15677562